Functional and molecular aspects of voltage-gated K+ channel beta subunits.

Localization and targeting of voltage-dependent ion channels in mammalian central neurons. Physiol Rev (2008) 2.90

Molecular diversity and regulation of renal potassium channels. Physiol Rev (2005) 2.56

K+ channels at the axon initial segment dampen near-threshold excitability of neocortical fast-spiking GABAergic interneurons. Neuron (2008) 2.22

The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab Rev (2008) 1.80

Weighing the evidence for a ternary protein complex mediating A-type K+ currents in neurons. J Physiol (2008) 1.64

Elimination of fast inactivation in Kv4 A-type potassium channels by an auxiliary subunit domain. Proc Natl Acad Sci U S A (2002) 1.61

Molecular determinants of cardiac transient outward potassium current (I(to)) expression and regulation. J Mol Cell Cardiol (2009) 1.58

AtKC1, a silent Arabidopsis potassium channel alpha -subunit modulates root hair K+ influx. Proc Natl Acad Sci U S A (2002) 1.55

Preparation, functional characterization, and NMR studies of human KCNE1, a voltage-gated potassium channel accessory subunit associated with deafness and long QT syndrome. Biochemistry (2007) 1.35

Kv4 channels exhibit modulation of closed-state inactivation in inside-out patches. Biophys J (2001) 1.24

Functional coupling between the Kv1.1 channel and aldoketoreductase Kvbeta1. J Biol Chem (2008) 1.18

Spider-venom peptides as bioinsecticides. Toxins (Basel) (2012) 1.14

Mechanisms of cardiac potassium channel trafficking. J Physiol (2007) 1.09

Cdk-mediated phosphorylation of the Kvβ2 auxiliary subunit regulates Kv1 channel axonal targeting. J Cell Biol (2011) 1.06

KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels. Biophys J (2003) 1.03

Function and mechanism of axonal targeting of voltage-sensitive potassium channels. Prog Neurobiol (2011) 1.01

Isolation from cochlea of a novel human intronless gene with predominant fetal expression. J Assoc Res Otolaryngol (2004) 1.01

Diverse roles for auxiliary subunits in phosphorylation-dependent regulation of mammalian brain voltage-gated potassium channels. Pflugers Arch (2011) 0.96

Function of K+ channels in the intestinal epithelium. J Membr Biol (2003) 0.95

Altered state dependence of c-type inactivation in the long and short forms of human Kv1.5. J Gen Physiol (2001) 0.94

Kv1.5 is a major component underlying the A-type potassium current in retinal arteriolar smooth muscle. Am J Physiol Heart Circ Physiol (2006) 0.93

Localization of Kv1.3 channels in the immunological synapse modulates the calcium response to antigen stimulation in T lymphocytes. J Immunol (2009) 0.90

A-type potassium currents active at subthreshold potentials in mouse cerebellar Purkinje cells. J Physiol (2002) 0.87

Signaling complexes of voltage-gated calcium channels. Channels (Austin) (2011) 0.87

Control of voltage-gated potassium channel Kv2.2 expression by pyruvate-isocitrate cycling regulates glucose-stimulated insulin secretion. J Biol Chem (2013) 0.86

Oxidation of NADPH on Kvbeta1 inhibits ball-and-chain type inactivation by restraining the chain. Proc Natl Acad Sci U S A (2011) 0.85

Kv1 potassium channel complexes in vivo require Kvbeta2 subunits in dorsal spinal neurons. J Neurophysiol (2008) 0.85

Molecular and Functional Differences between Heart mKv1.7 Channel Isoforms. J Gen Physiol (2006) 0.82

Triple N-glycosylation in the long S5-P loop regulates the activation and trafficking of the Kv12.2 potassium channel. J Biol Chem (2009) 0.82

In vivo analysis of Kvbeta2 function in Xenopus embryonic myocytes. J Physiol (2002) 0.81

Dendritic Kv3.3 potassium channels in cerebellar purkinje cells regulate generation and spatial dynamics of dendritic Ca2+ spikes. J Neurophysiol (2010) 0.80

Two functional inhibitory circuits are comprised of a heterogeneous population of fast-spiking cortical interneurons. Neuroscience (2014) 0.80

Obstructive Sleep Apnea and Circulating Potassium Channel Levels. J Am Heart Assoc (2016) 0.78

Acacetin inhibits glutamate release and prevents kainic acid-induced neurotoxicity in rats. PLoS One (2014) 0.78

The Caenorhabditis elegans iodotyrosine deiodinase ortholog SUP-18 functions through a conserved channel SC-box to regulate the muscle two-pore domain potassium channel SUP-9. PLoS Genet (2014) 0.77

Nuclear localization and functional characteristics of voltage-gated potassium channel Kv1.3. J Biol Chem (2015) 0.77

Potentiation of the Kv1 family K(+) channel by cortisone analogues. ACS Chem Biol (2012) 0.76

Berberine Inhibits the Release of Glutamate in Nerve Terminals from Rat Cerebral Cortex. PLoS One (2013) 0.76

Genome-wide DNA hydroxymethylation identifies potassium channels in the nucleus accumbens as discriminators of methamphetamine addiction and abstinence. Mol Psychiatry (2016) 0.76

Molecular Basis of Functional Myocardial Potassium Channel Diversity. Card Electrophysiol Clin (2016) 0.76

Myricetin inhibits the release of glutamate in rat cerebrocortical nerve terminals. J Med Food (2014) 0.75

Saikosaponin a Enhances Transient Inactivating Potassium Current in Rat Hippocampal CA1 Neurons. Evid Based Complement Alternat Med (2013) 0.75

Synaptotagmin I delays the fast inactivation of Kv1.4 channel through interaction with its N-terminus. Mol Brain (2014) 0.75

Idebenone inhibition of glutamate release from rat cerebral cortex nerve endings by suppression of voltage-dependent calcium influx and protein kinase A. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.75

Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res (2000) 7.29

Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell (1994) 6.67

Molecular basis of functional diversity of voltage-gated potassium channels in mammalian brain. EMBO J (1989) 5.66

Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) (1997) 5.03

Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning. Science (1998) 4.47

Cortical language localization in left, dominant hemisphere. An electrical stimulation mapping investigation in 117 patients. J Neurosurg (1989) 4.18

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 3.87

Attainment and adjustment in two geographical areas. I--The prevalence of psychiatric disorder. Br J Psychiatry (1975) 3.79

ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci (2001) 3.72

Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation (1990) 3.52

Hypoglycemic symptoms and frequency of severe hypoglycemia in patients treated with human and animal insulin preparations. Diabetes Care (1991) 3.51

Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol (1985) 3.50

Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med (1995) 3.47

Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med (1994) 3.24

Alpha-CaMKII-dependent plasticity in the cortex is required for permanent memory. Nature (2001) 3.04

Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency. Proc Natl Acad Sci U S A (2004) 2.97

Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J Clin Invest (1984) 2.88

The dorsal hippocampus is essential for context discrimination but not for contextual conditioning. Behav Neurosci (1998) 2.86

c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem (2000) 2.71

The role of BK-type Ca2+-dependent K+ channels in spike broadening during repetitive firing in rat hippocampal pyramidal cells. J Physiol (1999) 2.70

Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J (1999) 2.64

Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care (1987) 2.50

Presynaptic Ca2+-activated K+ channels in glutamatergic hippocampal terminals and their role in spike repolarization and regulation of transmitter release. J Neurosci (2001) 2.48

Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet (1981) 2.36

Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med (1999) 2.36

Measurement of the movement of the S4 segment during the activation of a voltage-gated potassium channel. Pflugers Arch (1997) 2.22

Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia (1983) 2.18

Modified hippocampal long-term potentiation in PKC gamma-mutant mice. Cell (1993) 2.14

Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat Genet (2001) 2.10

Long-term memory underlying hippocampus-dependent social recognition in mice. Hippocampus (2000) 2.08

Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription. EMBO J (2001) 2.08

Spaced training induces normal long-term memory in CREB mutant mice. Curr Biol (1997) 2.07

PKA mediates the effects of monoamine transmitters on the K+ current underlying the slow spike frequency adaptation in hippocampal neurons. Neuron (1993) 2.04

Conserved Kv4 N-terminal domain critical for effects of Kv channel-interacting protein 2.2 on channel expression and gating. J Biol Chem (2001) 2.04

Current classifications of HIV-associated periodontal diseases. Br Dent J (1993) 2.03

Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med (1998) 2.03

Sleep and depression--results from psychobiological studies: an overview. Biol Psychol (2001) 2.02

Effect of age on excess mortality in obesity. JAMA (1999) 2.01

Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry (2004) 2.00

Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia (1997) 1.95

Oxidative damage to DNA: formation, measurement, and biological significance. Rev Physiol Biochem Pharmacol (1997) 1.91

Glucose metabolism in perfused skeletal muscle. Effects of starvation, diabetes, fatty acids, acetoacetate, insulin and exercise on glucose uptake and disposition. Biochem J (1976) 1.90

The formation of glutamine and alanine in skeletal muscle. J Biol Chem (1974) 1.90

Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study. Diabetologia (1987) 1.87

Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus? Diabetologia (1990) 1.84

Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. J Neurosci (2001) 1.84

Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol (1995) 1.82

Kv beta 1 subunit binding specific for shaker-related potassium channel alpha subunits. Neuron (1996) 1.80

Regulation of glucose and ketone-body metabolism in brain of anaesthetized rats. Biochem J (1974) 1.78

Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron (1994) 1.71

Glucose metabolism in perfused skeletal muscle. Interaction of insulin and exercise on glucose uptake. Biochem J (1975) 1.71

A physiological role for ether-à-go-go K+ channels? Trends Neurosci (1997) 1.69

Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol (1997) 1.68

Pharmacokinetics and bioavailability of injected glucagon: differences between intramuscular, subcutaneous, and intravenous administration. Diabetes Care (1985) 1.67

Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia (1993) 1.67

Issues in the measurement of satisfaction with treatment. Am J Manag Care (1997) 1.67

Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest (1990) 1.66

Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains. J Cell Biol (1998) 1.63

Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection. J Infect Dis (1995) 1.63

Assessment of excess mortality in obesity. Am J Epidemiol (1998) 1.62

Computer-assisted behavioral assessment of Pavlovian fear conditioning in mice. Learn Mem (2000) 1.61

Prevalence and treatment of insomnia in general practice. A longitudinal study. Eur Arch Psychiatry Clin Neurosci (1993) 1.61

Environmental signals controlling production of hemagglutinin/protease in Vibrio cholerae. Infect Immun (2001) 1.61

Glucose metabolism in rat skeletal muscle at rest. Effect of starvation, diabetes, ketone bodies and free fatty acids. Diabetes (1974) 1.61

Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med (1999) 1.59

Lack of binding of human C3, in its native state, to C3b receptors. J Immunol (1981) 1.57

Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes. Lancet (1988) 1.56

Recurrent aphthae: treatment with vitamin B12, folic acid, and iron. Br Med J (1975) 1.56

Single-cell mRNA expression of HCN1 correlates with a fast gating phenotype of hyperpolarization-activated cyclic nucleotide-gated ion channels (Ih) in central neurons. Eur J Neurosci (2000) 1.53

Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: report of a pilot study. J Pediatr (1989) 1.53

The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol (1997) 1.52

Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule. Infect Immun (1983) 1.51

Prevalence of insomnia in elderly general practice attenders and the current treatment modalities. Acta Psychiatr Scand (1994) 1.51

Uncontrolled-rate freezing and storage at -80 degrees C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion (2001) 1.51

Reduced K+ channel inactivation, spike broadening, and after-hyperpolarization in Kvbeta1.1-deficient mice with impaired learning. Learn Mem (1999) 1.51

Noninvasive estimation of pulmonary artery diastolic pressure in patients with tricuspid regurgitation by Doppler echocardiography. Chest (1999) 1.51

Action profiles of fast onset insulin analogues. Diabetologia (1990) 1.50

Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons. EMBO J (1999) 1.50

Obstructive sleep apnea is a risk factor for difficult endotracheal intubation. Minerva Anestesiol (2011) 1.49

Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood (1997) 1.48

Unsuspected cardiac abnormalities in the acquired immune deficiency syndrome. An echocardiographic study. Chest (1989) 1.48

Echocardiographic detection of transient right heart thrombus: now you see it, now you don't. Am Heart J (1991) 1.48

Functional differences between the 40 kDa and 50 to 70 kDa IgG Fc receptors on human neutrophils revealed by elastase treatment and antireceptor antibodies. J Immunol (1988) 1.48

Test-retest reliability and validity of the Structured Interview for Sleep Disorders According to DSM-III-R. Am J Psychiatry (1993) 1.46

Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS. J Infect Dis (1988) 1.45

Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest (1988) 1.42

Possible risk of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease. Diabetologia (1997) 1.42

Captopril, blood pressure, and diabetic nephropathy. JAMA (1994) 1.42

[Chronic fatigue syndrome. Definition, diagnostic measures and therapeutic possibilities]. Nervenarzt (1996) 1.42

Hairy leukoplakia--a histological study. Histopathology (1991) 1.41

Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin. Diabet Med (1996) 1.41

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci (1997) 1.41

Hemodialysis of children: a review. Tex Med (1976) 1.40

Recent non-sterile inoculation injuries to dental professionals in the Lothian region of Scotland. Br Dent J (1994) 1.39

[The metabolic effects of beta-receptor blockers. What is of practical importance in antihypertensive therapy?]. Dtsch Med Wochenschr (1992) 1.39

[Significance of historical and current hallucinogenic research in psychiatry]. Nervenarzt (1993) 1.39

[Differential indications for psychotherapy exemplified by depression]. Nervenarzt (2011) 1.39

An international survey in postgraduate training in Oral Medicine. Oral Dis (2011) 1.39